The Impact of Telemonitoring on Compliance and Outcomes of Patients Undergoing Automated Peritoneal Dialysis With SHARESOURCE
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 50
- 主要终点
- Change of baseline patients' non-compliance rate at 3 months
研究概览
简要总结
This study is to investigate the non-compliance rate of patients undergoing automated peritoneal dialysis by using automated peritoneal dialysis with SHARESOURCE software, and to evaluate if telemonitoring can improve peritoneal dialysis compliance and outcomes in the observation period.
详细描述
The non-compliance of patients receiving automated peritoneal dialysis (APD) is around 10-20%, and was believed to be under-estimated. Recently, a two-way telehealth system, SHARESOURCE software, provide practitioners real-time monitoring and recording of the therapy of APD.
By using this APD with SHARESOURCE software, we want to investigate the non-compliance rate of patients undergoing automated peritoneal dialysis, want to see if it can improve peritoneal dialysis compliance and outcomes in the observation period.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •stable received peritoneal dialysis for over 1 year. Use automated peritoneal dialysis machine regularly by him/herself.
排除标准
- •Acute hospitalization events due to acute coronary syndrome, stroke, heart failure, liver cirrhosis, systemic infection in 1 month.
- •Life expectancy <1 year
- •Peritoneal dialysis prescriptions will be scheduled or expected to change in 3 months
结局指标
主要结局
Change of baseline patients' non-compliance rate at 3 months
时间窗: baseline(between week 0 and 12) and 3 months(week 12 and week 24)
Non compliance rate was calculated by the days of non-compliance divided by days of APD therapy
次要结局
- Change of baseline peritoneal dialysis adequacy at 3 and 6 months(baseline, week 12 and week 24)
- peritonitis rate (patient-month)(follow up to week 60)
- Change of telephone contact frequency(baseline(between week 0 and 12) and 3 months(week 12 and week 24))
- Change of baseline uremic toxin level at 3 and 6 months(baseline, week 12 and week 24)
- change of body composition analysis(baseline, week 12 and week 24)
- Hospitalization rate(follow up to week 60)